---
document_datetime: 2025-12-29 14:34:39
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/clopidogrel-1a-pharma.html
document_name: clopidogrel-1a-pharma.html
version: success
processing_time: 0.102373
conversion_datetime: 2025-12-30 01:54:49.802049
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Clopidogrel 1A Pharma

[RSS](/en/individual-human-medicine.xml/66353)

##### Withdrawn

This medicine's authorisation has been withdrawn

clopidogrel Medicine Human Withdrawn

On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [More information on Clopidogrel 1A Pharma](#more-information-on-clopidogrel-1a-pharma-1281)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On the 28 July 2009 the European Commission issued a marketing authorisation valid throughout the European Union for the medicinal product Clopidogrel 1A Pharma, a medicine that contains the active substance clopidogrel, which had been approved in adults for the prevention of atherothrombotic events in:

- Patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.
- Patients suffering from acute coronary syndrome:
    - Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (ASA).
    - ST segment elevation acute myocardial infarction, in combination with ASA in medically treated patients eligible for thrombolytic therapy. For further information please refer to section 5.1.

The marketing authorisation holder (MAH) responsible for Clopidogrel 1A Pharma was Acino Pharma GmBH. The European Commission was notified by a letter dated 20 December 2010 of the MAH's decision to voluntarily withdraw the marketing authorisation as of the Commission Decision date for Clopidogrel 1A Pharma for commercial reasons. Clopidogrel 1A Pharma was not marketed in any European country. On 1 February 2011 the European Commission issued a decision to withdraw the marketing authorisation for Clopidogrel 1A Pharma.

Pursuant to this decision the European Public Assessment Report for Clopidogrel 1A Pharma is updated to reflect that the marketing authorisation is no longer valid.

Clopidogrel 1A Pharma : EPAR - Summary for the public

English (EN) (264.06 KB - PDF)

**First published:** 08/09/2009

**Last updated:** 28/02/2011

[View](/en/documents/overview/clopidogrel-1a-pharma-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-380)

български (BG) (429 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/bg/documents/overview/clopidogrel-1a-pharma-epar-summary-public_bg.pdf)

español (ES) (266.07 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/es/documents/overview/clopidogrel-1a-pharma-epar-summary-public_es.pdf)

čeština (CS) (400.48 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/cs/documents/overview/clopidogrel-1a-pharma-epar-summary-public_cs.pdf)

dansk (DA) (265.13 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/da/documents/overview/clopidogrel-1a-pharma-epar-summary-public_da.pdf)

Deutsch (DE) (267 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/de/documents/overview/clopidogrel-1a-pharma-epar-summary-public_de.pdf)

eesti keel (ET) (264.62 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/et/documents/overview/clopidogrel-1a-pharma-epar-summary-public_et.pdf)

ελληνικά (EL) (443.13 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/el/documents/overview/clopidogrel-1a-pharma-epar-summary-public_el.pdf)

français (FR) (266.53 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/fr/documents/overview/clopidogrel-1a-pharma-epar-summary-public_fr.pdf)

italiano (IT) (265.52 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/it/documents/overview/clopidogrel-1a-pharma-epar-summary-public_it.pdf)

latviešu valoda (LV) (399.98 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/lv/documents/overview/clopidogrel-1a-pharma-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (398.13 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/lt/documents/overview/clopidogrel-1a-pharma-epar-summary-public_lt.pdf)

magyar (HU) (390.37 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/hu/documents/overview/clopidogrel-1a-pharma-epar-summary-public_hu.pdf)

Malti (MT) (401.02 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/mt/documents/overview/clopidogrel-1a-pharma-epar-summary-public_mt.pdf)

Nederlands (NL) (265.96 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/nl/documents/overview/clopidogrel-1a-pharma-epar-summary-public_nl.pdf)

polski (PL) (407.58 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/pl/documents/overview/clopidogrel-1a-pharma-epar-summary-public_pl.pdf)

português (PT) (265.9 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/pt/documents/overview/clopidogrel-1a-pharma-epar-summary-public_pt.pdf)

română (RO) (370.65 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/ro/documents/overview/clopidogrel-1a-pharma-epar-summary-public_ro.pdf)

slovenčina (SK) (426.4 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/sk/documents/overview/clopidogrel-1a-pharma-epar-summary-public_sk.pdf)

slovenščina (SL) (354.65 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/sl/documents/overview/clopidogrel-1a-pharma-epar-summary-public_sl.pdf)

Suomi (FI) (264.89 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/fi/documents/overview/clopidogrel-1a-pharma-epar-summary-public_fi.pdf)

svenska (SV) (265.24 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/sv/documents/overview/clopidogrel-1a-pharma-epar-summary-public_sv.pdf)

## Product information

Clopidogrel 1A Pharma : EPAR - Product Information

English (EN) (512.52 KB - PDF)

**First published:** 13/10/2009

**Last updated:** 28/02/2011

[View](/en/documents/product-information/clopidogrel-1a-pharma-epar-product-information_en.pdf)

[Other languages (21)](#file-language-dropdown-556)

български (BG) (1.19 MB - PDF)

**First published:**

13/10/2009

**Last updated:**

28/02/2011

[View](/bg/documents/product-information/clopidogrel-1a-pharma-epar-product-information_bg.pdf)

español (ES) (525.85 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

28/02/2011

[View](/es/documents/product-information/clopidogrel-1a-pharma-epar-product-information_es.pdf)

čeština (CS) (854.23 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

28/02/2011

[View](/cs/documents/product-information/clopidogrel-1a-pharma-epar-product-information_cs.pdf)

dansk (DA) (520.45 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

28/02/2011

[View](/da/documents/product-information/clopidogrel-1a-pharma-epar-product-information_da.pdf)

Deutsch (DE) (531.69 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

28/02/2011

[View](/de/documents/product-information/clopidogrel-1a-pharma-epar-product-information_de.pdf)

eesti keel (ET) (512.36 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

28/02/2011

[View](/et/documents/product-information/clopidogrel-1a-pharma-epar-product-information_et.pdf)

ελληνικά (EL) (1.26 MB - PDF)

**First published:**

13/10/2009

**Last updated:**

28/02/2011

[View](/el/documents/product-information/clopidogrel-1a-pharma-epar-product-information_el.pdf)

français (FR) (537.44 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

28/02/2011

[View](/fr/documents/product-information/clopidogrel-1a-pharma-epar-product-information_fr.pdf)

italiano (IT) (522.87 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

28/02/2011

[View](/it/documents/product-information/clopidogrel-1a-pharma-epar-product-information_it.pdf)

latviešu valoda (LV) (944.42 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

28/02/2011

[View](/lv/documents/product-information/clopidogrel-1a-pharma-epar-product-information_lv.pdf)

lietuvių kalba (LT) (588.7 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

28/02/2011

[View](/lt/documents/product-information/clopidogrel-1a-pharma-epar-product-information_lt.pdf)

magyar (HU) (893 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

28/02/2011

[View](/hu/documents/product-information/clopidogrel-1a-pharma-epar-product-information_hu.pdf)

Malti (MT) (869.35 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

28/02/2011

[View](/mt/documents/product-information/clopidogrel-1a-pharma-epar-product-information_mt.pdf)

Nederlands (NL) (538.17 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

28/02/2011

[View](/nl/documents/product-information/clopidogrel-1a-pharma-epar-product-information_nl.pdf)

polski (PL) (926.14 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

28/02/2011

[View](/pl/documents/product-information/clopidogrel-1a-pharma-epar-product-information_pl.pdf)

português (PT) (457.39 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

28/02/2011

[View](/pt/documents/product-information/clopidogrel-1a-pharma-epar-product-information_pt.pdf)

română (RO) (600.83 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

28/02/2011

[View](/ro/documents/product-information/clopidogrel-1a-pharma-epar-product-information_ro.pdf)

slovenčina (SK) (870.69 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

28/02/2011

[View](/sk/documents/product-information/clopidogrel-1a-pharma-epar-product-information_sk.pdf)

slovenščina (SL) (801.06 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

28/02/2011

[View](/sl/documents/product-information/clopidogrel-1a-pharma-epar-product-information_sl.pdf)

Suomi (FI) (524.94 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

28/02/2011

[View](/fi/documents/product-information/clopidogrel-1a-pharma-epar-product-information_fi.pdf)

svenska (SV) (535.63 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

28/02/2011

[View](/sv/documents/product-information/clopidogrel-1a-pharma-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IA/0002 01/02/2011

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Clopidogrel 1A Pharma : EPAR - All Authorised presentations

English (EN) (224.85 KB - PDF)

**First published:** 08/09/2009

**Last updated:** 28/02/2011

[View](/en/documents/all-authorised-presentations/clopidogrel-1a-pharma-epar-all-authorised-presentations_en.pdf)

[Other languages (21)](#file-language-dropdown-554)

български (BG) (310.7 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/bg/documents/all-authorised-presentations/clopidogrel-1a-pharma-epar-all-authorised-presentations_bg.pdf)

español (ES) (225.32 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/es/documents/all-authorised-presentations/clopidogrel-1a-pharma-epar-all-authorised-presentations_es.pdf)

čeština (CS) (298.64 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/cs/documents/all-authorised-presentations/clopidogrel-1a-pharma-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (224.99 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/da/documents/all-authorised-presentations/clopidogrel-1a-pharma-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (225.22 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/de/documents/all-authorised-presentations/clopidogrel-1a-pharma-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (225.28 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/et/documents/all-authorised-presentations/clopidogrel-1a-pharma-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (321.04 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/el/documents/all-authorised-presentations/clopidogrel-1a-pharma-epar-all-authorised-presentations_el.pdf)

français (FR) (225.74 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/fr/documents/all-authorised-presentations/clopidogrel-1a-pharma-epar-all-authorised-presentations_fr.pdf)

italiano (IT) (224.99 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/it/documents/all-authorised-presentations/clopidogrel-1a-pharma-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (300.54 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/lv/documents/all-authorised-presentations/clopidogrel-1a-pharma-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (304.46 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/lt/documents/all-authorised-presentations/clopidogrel-1a-pharma-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (301.3 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/hu/documents/all-authorised-presentations/clopidogrel-1a-pharma-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (298.46 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/mt/documents/all-authorised-presentations/clopidogrel-1a-pharma-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (225.08 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/nl/documents/all-authorised-presentations/clopidogrel-1a-pharma-epar-all-authorised-presentations_nl.pdf)

polski (PL) (265.23 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/pl/documents/all-authorised-presentations/clopidogrel-1a-pharma-epar-all-authorised-presentations_pl.pdf)

português (PT) (225.13 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/pt/documents/all-authorised-presentations/clopidogrel-1a-pharma-epar-all-authorised-presentations_pt.pdf)

română (RO) (287.24 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/ro/documents/all-authorised-presentations/clopidogrel-1a-pharma-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (263.63 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/sk/documents/all-authorised-presentations/clopidogrel-1a-pharma-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (234.23 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/sl/documents/all-authorised-presentations/clopidogrel-1a-pharma-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (225.23 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/fi/documents/all-authorised-presentations/clopidogrel-1a-pharma-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (225.69 KB - PDF)

**First published:**

08/09/2009

**Last updated:**

28/02/2011

[View](/sv/documents/all-authorised-presentations/clopidogrel-1a-pharma-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Clopidogrel 1A Pharma Active substance clopidogrel International non-proprietary name (INN) or common name clopidogrel Therapeutic area (MeSH) Peripheral Vascular Diseases Anatomical therapeutic chemical (ATC) code B01AC04

### Pharmacotherapeutic group

Antithrombotic agents

### Therapeutic indication

Clopidogrel is indicated in adults for the prevention of atherothrombotic events in:

- Patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.
- Patients suffering from acute coronary syndrome:

For further information please refer to section 5.1.

## Authorisation details

EMA product number EMEA/H/C/001054

Generic

This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see [Generic and hybrid medicines](/node/69107) .

Marketing authorisation holder

Acino Pharma GmbH

Am Windfeld 35

Marketing authorisation issued 28/07/2009 Withdrawal of marketing authorisation 01/02/2011 Revision 1

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Clopidogrel 1A Pharma : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (288.89 KB - PDF)

**First published:** 13/10/2009

**Last updated:** 28/02/2011

[View](/en/documents/procedural-steps-after/clopidogrel-1a-pharma-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Clopidogrel 1A Pharma-H-1054-A-20-0004: EPAR - Assessment Report

Adopted

Reference Number: EMA/11498/2011

English (EN) (304.73 KB - PDF)

**First published:** 28/02/2011

**Last updated:** 28/02/2011

[View](/en/documents/variation-report/clopidogrel-1a-pharma-h-1054-20-0004-epar-assessment-report_en.pdf)

## Initial marketing authorisation documents

Clopidogrel 1A Pharma : EPAR - Public assessment report

English (EN) (411.1 KB - PDF)

**First published:** 08/09/2009

**Last updated:** 28/02/2011

[View](/en/documents/assessment-report/clopidogrel-1a-pharma-epar-public-assessment-report_en.pdf)

#### More information on Clopidogrel 1A Pharma

Questions and answers on the precautionary recall of batches of clopidogrel-containing medicines

Reference Number: EMA/179698/2010

English (EN) (58.98 KB - PDF)

**First published:** 25/03/2010

**Last updated:** 25/03/2010

[View](/en/documents/medicine-qa/questions-and-answers-precautionary-recall-batches-clopidogrel-containing-medicines_en.pdf)

**This page was last updated on** 28/02/2011

## Share this page

[Back to top](#main-content)